Market Snapshot
| Study Period: | 2018 - 2026 |
| Base Year: | 2021 |
| Fastest Growing Market: | Asia Pacific |
| Largest Market: | North America |
| CAGR: | 9.29 % |
|
Need a report that reflects how COVID-19 has impacted this market and its growth?
Market Overview
The government funding for the development of regenerative medicine has been increasing in most developed countries, because of its applications in organ transplantation, tissue engineering, and various other applications. In the United States, two major government agencies, National Institutes of Health (NIH) and California Institute of Regenerative Medicine (CIRM), fund almost all the translational researches and regenerative medicine development in the country. It is estimated that the United States government invests around USD 800-900 million every year in stem cell research. Additionally, other factors such as the high prevalence of cardiac and malignant diseases, and rising demand for regenerative medicines are expected to drive the market.
Scope of the Report
As per the scope of the report, Human embryonic stem cells are pluripotent stem cells derived from the inner cell mass of a blastocyst, an early-stage pre-implantation embryo. These stem cells are used for the treatment of various diseases.
| By Application | |
| Regenerative Medicine | |
| Stem Cell Biology Research | |
| Tissue Engineering | |
| Toxicology Testing |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| Rest of World |
Key Market Trends
Stem Cell Biology Research Segment is Expected to Show Better Growth in the Forecast Years
Based on the application, it is segmented into regenerative medicine, stem cell biology research, tissue engineering, and toxicology testing. Stem cell biology research will show better growth, owing to the high prevalence of cardiac and malignant diseases. An article published by the ISSCR (International Society for Stem Cell Research) reported that the stem cells hold potential for the treatment of Parkinson’s disease in humans. Recently, one of the market players, International Stem Cell Corporation (ISCO), received the patent covering methods for generating HLA homozygous parthenogenetic human stem cell lines from unfertilized eggs. The patent was issued in Australia. Furthermore, to boost the pace of stem cell research, the government is providing funding opportunities to researchers. Thus, owing to these factors, the market studied is expected to witness a high growth rate over the forecast period.
To understand key trends, Download Sample Report
North America Dominates the Human Embryonic Stem Cells Market
The human embryonic stem cells market is expected to dominate in the North America region owing to extensive research activities, along with high burden of chronic diseases and genetic disorders in the region. The United States also shows a high incidence of other diseases, such as diabetes, heart disease, renal failure, and osteoporosis. Human embryonic stem cells have high potential for use in treatment and may become a standard of care for these diseases. Additionally, the FDA has approved clinical trials, which indicated the use of stem cells. Hence, these factors are expected to influence the growth of the human embryonic stem cells market over the forecast period.
To understand geography trends, Download Sample Report
Competitive Landscape
The global players into the human embryonic stem cells market are Astellas Pharma Inc, PeproTech Inc, Lineage Cell Therapeutics Inc, Merck KGaA, PromoCell GmbH, STEMCELL Technologies Inc, Thermo Fisher Scientific and ViaCyte, Inc.
Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 High Prevalence of Cardiac and Malignant Diseases
-
4.2.2 Rising Demand for Regenerative Medicines
-
4.2.3 Increasing Support from Governments and Government and Private Institutions
-
-
4.3 Market Restraints
-
4.3.1 High Cost of the Procedure
-
4.3.2 Stringent Regulatory Guidelines
-
-
4.4 Porter's Five Forces Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Application
-
5.1.1 Regenerative Medicine
-
5.1.2 Stem Cell Biology Research
-
5.1.3 Tissue Engineering
-
5.1.4 Toxicology Testing
-
-
5.2 Geography
-
5.2.1 North America
-
5.2.1.1 United States
-
5.2.1.2 Canada
-
5.2.1.3 Mexico
-
-
5.2.2 Europe
-
5.2.2.1 Germany
-
5.2.2.2 United Kingdom
-
5.2.2.3 France
-
5.2.2.4 Italy
-
5.2.2.5 Spain
-
5.2.2.6 Rest of Europe
-
-
5.2.3 Asia-Pacific
-
5.2.3.1 China
-
5.2.3.2 Japan
-
5.2.3.3 India
-
5.2.3.4 Australia
-
5.2.3.5 South Korea
-
5.2.3.6 Rest of Asia-Pacific
-
-
5.2.4 Rest of World
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Astellas Pharma Inc
-
6.1.2 PeproTech Inc
-
6.1.3 Lineage Cell Therapeutics Inc
-
6.1.4 Merck KGaA
-
6.1.5 PromoCell GmbH
-
6.1.6 STEMCELL Technologies Inc
-
6.1.7 Thermo Fisher Scientific
-
6.1.8 ViaCyte, Inc.
-
6.1.9 Takara Bio Inc.
-
*List Not Exhaustive -
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Human Embryonic Stem Cells Market market is studied from 2018 - 2026.
What is the growth rate of Human Embryonic Stem Cells Market?
The Human Embryonic Stem Cells Market is growing at a CAGR of 9.29% over the next 5 years.
Which region has highest growth rate in Human Embryonic Stem Cells Market?
Asia Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Human Embryonic Stem Cells Market?
North America holds highest share in 2020.
Who are the key players in Human Embryonic Stem Cells Market?
Merck KGaA, STEMCELL Technologies Inc., Thermo Fisher Scientific, Lineage cell therapeutics , ViaCyte Inc are the major companies operating in Human Embryonic Stem Cells Market.
